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Commitment to divide is one of the most crucial steps in
the mammalian cell division cycle. It is critical for tissue and
organismal homeostasis, and consequently is highly regulated.
The vast majority of cancers evade proliferative control, further
emphasizing the importance of the commitment step in cell
cycle regulation. The Retinoblastoma (RB) tumor suppressor
pathway regulates this decision-making step. Since being
the subject of Knudson’s ‘two hit hypothesis’, there has been
considerable interest in understanding pRB’s role in cancer. It
is best known for repressing E2F dependent transcription of
cell cycle genes. However, pRB’s role in controlling chromatin
structure is expanding and bringing it into new regulatory
paradigms. In this review we discuss pRB function through
protein-protein interactions, at the level of transcriptional
regulation of individual promoters and in organizing higher
order chromatin domains.

Introduction
The retinoblastoma protein (pRB) was the first tumor suppressor to be discovered, and it regulates the G1 to S phase transition at the beginning of the cell cycle.1 Deregulation of cell cycle
control in cancer requires inactivation of this growth regulatory
function.2 Not surprisingly, the RB1 gene and components of the
pRB regulatory pathway are mutated or silenced in most human
cancers.2,3 The RB protein is a member of the pocket protein
family, which also includes similar proteins with overlapping
functions: p107 and p130.4 However, the vast majority of tumor
derived mutations identified in this family are found in the RB1
gene, suggesting a unique role for pRB among its siblings.4,5 For
this reason, understanding the function of pRB is of considerable
interest to cancer researchers.
pRB’s tumor suppressor property is generally attributed to its
ability to repress transcription of cell cycle genes by binding to
and inhibiting the E2F family of transcription factors.6-8 Upon
growth factor stimulation, pRB is inactivated through phosphorylation by cyclin-dependent kinases (CDKs) releasing the E2F
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proteins to activate transcription of cell cycle genes.1 Viral oncoproteins, like E1A, bind to pRB, preventing it from interacting
with E2Fs and thereby inducing cell proliferation.9,10 Similarly,
in cancer cells, the pRB pathway is inactivated either by direct
mutation of the RB1 gene, deregulation of CDKs or inactivation
of cyclin-dependent kinase inhibitors such as p16INK4A. These
mutational events serve to stably deregulate E2F transcription.2
In this model of pRB function, it is a local transcriptional repressor that regulates the expression of genes through direct interaction with the activation domain of E2F transcription factors.
While this model provides a relatively simplistic and straight
forward mechanistic basis for pRB function, pRB appears to be
capable of exerting broader effects on transcriptional control and
chromatin structure.
In addition to inhibiting E2Fs through direct interaction,
pRB is also able to actively repress gene transcription mediated
by neighboring transcription factors when recruited to promoters
by E2Fs.11-13 These observations suggested that pRB can inhibit
transcriptional activation throughout a gene’s promoter. In fact,
pRB has been found to associate with a number of proteins that
can regulate chromatin structure and transcription at E2Fresponsive promoters. These findings have suggested that pRB
is recruited to promoters by sequence-specific transcription factors such as E2Fs. In turn, pRB recruits co-repressors to these
promoters, which can remodel chromatin in neighboring regions
to silence transcription. Examples of co-repressors bound by pRB
include histone deacetylases (HDAC1, HDAC2),14-16 histone
demethylases (RBP2),17 DNA methyl transferases (DNMT1),18
helicases (Brg1, Brm),19,20 histone methyl transferases (Suv39h1,
RIZ and Suv4–20h1/h2)21-23 and histone binding proteins like
HP1.21,24 The ability of pRB to bring these chromatin-regulating
activities to E2F-responsive promoters creates the opportunity to
influence a broader genomic region than just the DNA footprint
of the E2F transcription factor.
Beyond these two levels of regulatory control exerted by pRB
at promoters, recent evidence suggests a genome-wide role for
pRB in the regulation of large heterochromatin domains such
as pericentric heterochromatin, telomeres and senescence-associated heterochromatic foci. The RB protein has been shown
to interact with Suv4–20h1/h2 histone methyltransferases that
regulate the trimethylation of histone H4 lysine 20 (H4K20)

Cell Cycle

3189

©2012 Landes Bioscience. Do not distribute.

1

Figure 1. Transcriptional regulation by pRB through direct interactions.
(A) During G0/G1, pRB inhibits cell cycle gene expression by directly
blocking the trans-activating domain of E2F transcription factors.
(B) During bone differentiation, pRB binds to osteoblast specific transcription factor Runx2 and co-operates with it and Hes1 in the activation of osteoblast specific genes like osteopontin and osteocalcin.

at pericentric heterochromatin.22 Fibroblasts that lack all three
pRB family proteins or a knock in mutation in just pRB show
a decrease in tri-methylation of H4K20 at this heterochromatin domain.22,25 Conditional knockout of pRB in fibroblasts also
results in a similar reduction in H4K20 trimethylation at pericentric heterochromatin.26 Tri-methylation of H4K20 at telomeres is also found to be markedly reduced in cells lacking all
three pRB family proteins.22 This could be one of the reasons for
the elongated telomeres seen in these cells.27 In a similar manner,
pRB has been shown to be important for heterochromatin assembly during cellular senescence, where it is required for the formation of senescence-associated heterochromatic foci (SAHF).28,29
In addition, pRB has also been implicated in regulating chromosome condensation during mitosis.30 The condensin II complex and pRB physically interact, and this is required for proper
chromosome condensation during mitosis.31 Lack of this interaction causes defects in condensation that lead to lagging anaphase chromosomes and segregation defects. Condensation of
mitotic chromosomes and SAHF formation represent chromatin
organization at the broadest level, as they involve the compaction of entire chromosomes. Importantly, pRB’s role in chromosome condensation in mitosis is part of what makes it a tumor
suppressor.31
Similar to this introduction, the focus of this review will be
to highlight how our understanding of pRB function has evolved
over time from being a local transcriptional repressor that relied
on direct protein interactions at discreet genetic loci to a genomewide regulator of chromatin structure. In addition to highlighting recent findings that have contributed to this evolution in
thinking, we will also review the most recent findings on pRB
function in senescence. We will focus on this paradigm of growth
arrest, because it is a tumor-suppressive mechanism, and because
it best exemplifies how pRB coordinates these three levels of regulation in a single cell cycle arrest event.
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A number of pRB binding proteins include sequence-specific
transcription factors that regulate the expression of genes involved
in diverse physiological processes, including cell proliferation,
differentiation and cell death. Depending on the transcription
factor that is bound, and the physiological context, pRB has been
reported to act both as a transcriptional activator and a repressor.
This section will focus on current data that relates direct interactions between pRB and transcription factors with these two
regulatory outputs.
Inhibition of E2F transcription by pRB binding. Analysis
of pRB’s distribution across the genome in proliferating and
senescent fibroblasts using chromatin immunoprecipitation and
sequence analysis (ChIP-Seq) determined that the most abundant transcription factor binding sequence present in regions
bound by pRB was E2F.29 This, along with considerable previous
data, has placed pRB regulation of E2F-dependent transcription
at the center of pRB’s function in cell cycle control and tumor
suppression. The E2F family proteins that bind to pRB include
E2Fs 1–4, and these proteins must heterodimerize with a DP
family partner to bind DNA.6 The pRB binding domain of the
E2Fs is their transcriptional activation domain.32 Thus a simple
model that explains pRB’s E2F inhibition and transcriptional
repressor role is that pRB blocks the transactivation function of
E2Fs, thereby preventing the expression of the genes involved in
DNA replication and cell cycle progression (see Fig. 1A for an
illustration of this mechanism).
Further evidence for the importance of the pRB-E2F interaction comes from the study of viral oncogenes, such as adenovirus
E1A.9,10 E1A binds and dissociates E2Fs from pRB in a two-step
mechanism. First, E1A interacts with the pRB pocket domain
using a peptide motif called LXCXE.33,34 E1A then uses its conserved region 1 (CR1) domain to compete for the contact point
on pRB occupied by the E2F transcriptional activation domain.35
The disruption of pRB-E2F interactions by this mechanism is
required for activation of transcription by E1A.36 The LXCXE
and CR1 domains are also essential for the cellular transforming activity of E1A.37 Additional evidence for the importance
of this direct interaction comes from Rb1-/- cells derived from
knockout mouse embryos. They display increased expression of
E2F responsive genes like cyclin E and p107 and increased DNA
synthesis under serum-free conditions.38,39 Taken together, these
examples of E2F control by pRB demonstrate negative regulation
of transcription that is mediated by pRB when it stably binds the
transactivation domain of E2Fs.
Transcription factors activated in the presence of pRB. A
number of transcription factors involved in cellular differentiation have been proposed to be activated upon association with
pRB. These include MyoD during myogenesis,40 CBFA1/Runx2
during osteogenesis,41 and C/EBP and NF-IL6 during adipogeneis.42,43 It is important to emphasize that our mechanistic
knowledge of how pRB regulates these is minimal in comparison
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damage signaling that can activate transcription.50 This is quite
surprising given the depth of understanding of how pRB acts as
a repressor of E2F transcription described above. Understanding
how DNA damage can alter pRB-E2F1 complexes from one of
negative transcriptional regulation to one of activation is likely to
yield a great deal of insight into other transcriptional activation
paradigms involving pRB, such as with Runx2.
Ianari et al. have recently reported that pRB-E2F1 complexes can be found at pro-apoptotic promoters such as TAp73
in response to DNA double-strand breaks by ChIP analysis.50
Furthermore, ChIP re-ChIP experiments reveal that histone tail
modifications that are indicative of transcriptional activation are
found at the same promoters occupied by pRB-E2F1 complexes
and that TAp73 expression is increased at the same time. How
can this be reconciled with prior experiments that demonstrate
pRB binding and inhibition of E2F1? One clue comes from the
identification of a second binding site on pRB that is used exclusively by E2F1.51 In other words, E2F1 can bind to pRB through
two different configurations: one that is described above, where
E2F1’s transactivation domain is masked by the pRB pocket
when these proteins contact one another, and a second configuration that is mediated outside the activation domain on E2F1.
This exclusive contact between pRB and E2F1 is maintained
even when pRB is hyperphosphorylated and unable to bind to
other E2Fs.52 This is important, because Ianari et al. described
their pRB-E2F1 activation complex as containing phosphorylated pRB.50 Thus, it is tempting to speculate that DNA damage
signaling somehow supports or augments pRB’s unique interaction with E2F1, and that this complex is simply organized differently than other pRB-E2F complexes and this allows E2F1 to
activate transcription in the presence of pRB.
An additional clue as to how a pRB-E2F1 complex can have
a net positive effect on transcription comes from studies on posttranslational modifications of E2F1 following DNA damage.
Double-stranded breaks induce the phosphorylation of E2F1 at
Ser364.53 E2F1 modified at this site is found to be predominantly
in complex with hyperphosphorylated pRB following DNA
damage, implying that this is a pRB-E2F1 “specific” complex.54
In addition, this modified form of E2F1 is found at the TA-p73
promoter during transcriptional activation and induction of
apoptosis in response to DNA damage.54 It is possible that phosphorylation of E2F1 at Ser364 changes the binding confirmation of pRB-E2F1 complexes, switching them from repressive to
activating configurations. Alternatively, Ser364 phosphorylation
may be part of a signal that alleviates pRB-dependent transcriptional repression, thus creating an overall positive effect on transcriptional activation of TAp73.
Again, our knowledge of this mechanism is limited, as even
the models proposed above have involved piecing together data
from different studies utilizing different cell types and methodologies. It is also possible that the activation function of this
complex relies on the recruitment of co-factors that activate transcription through mechanisms that exert a broader influence on
the promoter. In this way seemingly direct effects of pRB on gene
expression may involve a broader promoter-wide influence.
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to the negative regulation of E2F above. As outlined above there
is clear structural, functional and genetic data that reveals how
direct interaction between pRB and E2F is utilized in transcriptional control. In contrast, the interactions between these
transcription factors and pRB have often been controversial, and
the nature of their interactions is not understood beyond simple
domain mapping experiments. Given that the emphasis of this
part of our review is on transcriptional regulation mediated by
direct protein-protein interactions, it is important to note that
some of pRB’s influence on transcriptional activation is likely to
be indirect. For example, pRB can bind and block the activity of
differentiation inhibitors like EID-1,44,45 ID246 and RBP2.17 As
a result the negative regulation of a negative regulator of differentiation results in the augmentation of transcription by factors
like MyoD. Thus, even seemingly direct interactions with pRB
may have somewhat indirect mechanisms that assist them. An
example that gives some of the best insight into direct proteinprotein interactions between pRB and a transcriptional activator
is Runx2/CBFA1/OSF-2 and this will be our focus for this section of the review.
During osteogenesis pRB interacts with the osteoblast specific transcription factor Runx2 to induce differentiation into
an osteogenic fate41 (see Fig. 1B for a diagram of this regulatory
paradigm). Using a series of in vitro experiments, pRB has been
shown to interact with the C terminus of Runx2 using its pocket
domain. In addition, ChIP experiments have demonstrated that
pRB associates with Runx2 at the osteoblast-specific promoters osteocalcin and osteopontin.41 Beyond recruiting pRB to
this promoter, Runx2 also recruits HES1 as part of this transcriptional activation complex.47 Thus, it is thought that differentiation signals lead Runx2 to increase expression of p27KIP1
to inhibit cyclin dependent kinase activity and arrest the cell
cycle. This, in turn, leads to dephosphorylation of pRB and it
and HES1 interact with Runx2 to activate transcription of late
markers of bone differentiation. Recent analysis of a bone-specific knockout of pRB in mice indicates that when complexes
of Runx2 and pRB can’t form, cells dedifferentiate from an
osteoblast fate to a more primitive mesenchymal cell type that
is capable of differentiating into both adipocytes or osteogenic
lineages.48,49
As stated above pRB-Runx2 interactions are the most thoroughly studied example of direct interaction between pRB and
a transcription factor leading to transcriptional activation. The
precise mechanism of how pRB acts as an activator of transcription is still not known. It could involve alterations in its structure
that allow it to switch between activating and repressing functions. Alternatively, it could also be recruiting other co-factors
that can activate transcription and in this way functions as an
adaptor when activating transcription. Regardless of our current
state of knowledge, this is an important issue for resolution in
the future, because it will determine exactly how direct pRB’s
involvement is in transcriptional activation.
Activation of transcription by pRB-E2F1 complexes. Recent
work on pRB regulation of E2F1 and apoptosis has suggested
that they can form a complex together in response to DNA

There: pRB Facilitates Transcriptional Regulation
Across the Promoter by Altering Chromatin
Structure
Apart from direct inhibition of transactivation by E2Fs described
above, pRB has also been shown to actively repress transcription
that is stimulated by factors elsewhere in the same promoter.11-13
This observation suggested that pRB might recruit co-repressors
to these promoters to exert a broader effect on transcription of
these genes. More recently it has been shown that pRB can influence chromatin structure at these promoters, and this is a likely
explanation for its promoter-wide effects. Many co-repressor
proteins that can bind to pRB have enzymatic activity and can
alter posttranslational modifications on histone tails to influence
transcription of the associated genes. This part of the review will
focus on the pRB protein interactions that affect local chromatin
structure and how these modifications regulate gene expression
(see Fig. 2 for an illustration of this type of regulation).
As described in the introduction, there are a number of cellular
proteins that pRB can recruit to promoters, where they act as corepressors. While the list of histone deacetylases, histone demethylases, DNA methyl transferases, helicases and histone methyl
transferases described in the introduction is quite impressive, the
data that describes their respective roles in regulating chromatin
structure and inhibiting transcription in conjunction with pRB
is often limited to only a few papers. The examples of chromatin
regulating mechanisms described below are selected because they
offer the most complete picture of how pRB influences chromatin
structure to provide promoter-wide regulation of transcription.
Histone deacetylases. The RB protein was shown to bind to
histone deacetylases through immunoprecipitation and western
blot experiments, as well as co-precipitation followed by catalytic
assays.14-16 Since these initial reports, a number of research groups
have characterized histone acetylation levels and HDAC occupancy at E2F target genes. A key transcriptional target at the G1
to S-phase transition for pRB and E2Fs is cyclin E1.55,56 A repressor module containing pRB and E2F transcription factors binds
an E2F site at the transcriptional start site of this gene.57 This
binding site coincides with a single nucleosome whose acetylation
levels are highly dynamic.58 Multiple histones in this nucleosome
are acetylated when cyclin E1 is transcribed and deacetylated
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Figure 2. Transcriptional regulation by pRB through local chromatin
changes. pRB can recruit co-repressors like HDAC to E2F responsive cell
cycle gene promoters to deacetylate histones and compact chromatin,
thereby stably repressing gene expression. In the case of cyclin E1 this
impinges on a single histone octomer, but in other instances can target
a broader region of the promoter.

when the promoter is silenced.58 The upstream regions of this promoter have relatively stable histone acetylation, suggesting that a
single nucleosome is the target of deacetylase activity recruited by
pRB.58 As confirmation that regulation of acetylation is the key
to controlling transcription at cyclin E1, the histone deacetylase
inhibitor trichostatin A can inhibit pRB-dependent repression of
this promoter.59 Similar observations have been made that pRB
family proteins utilize HDACs to repress transcription of a broad
group of E2F-responsive genes.60-62
The organization and structure of these repressive complexes
that contain HDACs, pRB and E2Fs remains unclear. Initially,
investigators pointed out that HDAC1 and 2 contain a peptide sequence that resembles the LXCXE motif found in viral
oncoproteins like E1A, TAg and E7.14 This suggested a direct
interaction between pRB and HDAC in a manner that is similar
to the viral oncoproteins. However, there are important differences between the viral CR2 region that contacts pRB and the
LXCXE-like sequence in HDAC1 and 2,63 and peptide sequences
from HDACs fail to bind pRB with similar affinity as the viralderived equivalent.64 It was also not immediately appreciated
that HDAC proteins are found in large multimeric protein complexes and, thus, their interaction with pRB may not be direct.
Specifically, Sin3 and CtBP complexes can contain HDACs and
are known to bind to pRB, suggesting that there are a number
of possible intermediaries.65-67 Regardless of the mechanism of
recruitment, the LXCXE binding site on pRB appears to be the
site of interaction for HDAC containing complexes. Peptide competitors containing the viral LXCXE sequence can compete for
pRB’s ability to recruit HDAC activity in precipitation assays.15,68
This suggests that regardless of how HDACs are brought to pRB,
their associated complex contacts pRB in a manner that at least
overlaps with the viral LXCXE contact point on pRB.
Taken together, these experiments demonstrate pRB regulation of transcription by recruiting HDAC activity to E2F promoters (Fig. 2). Surprisingly, many promoters have only had their
histone acetylation levels investigated in the immediate vicinity
of the transcriptional start site. Studies of cyclin E1 repression
of transcription by pRB and HDAC suggest it may not involve
modifications to histones beyond the immediate transcriptional
start site. However, by regulating histone deacetylation, pRB
can create changes in local chromatin structure that have relatively broad effects on transcriptional activation across the entire
promoter.
DNA-dependent helicases. The retinoblastoma protein has
also been found to associate with the core components (Brm
and Brg1) of the evolutionarily conserved SWI/SNF chromatin
remodeling apparatus.19,20 Brm and Brg1 each use ATPase activity
to mobilize nucleosomes along the DNA strand, remove histones
from DNA and/or promote the exchange of histone variants.
This activity alters nucleosomal structure such that accessibility
to binding sites by transcription factors and other transcriptional
machinery is increased.69-71 This generally leads to gene activation;72 however, there are examples of how Brm and Brg1 can
promote transcriptional repression.73 In addition, there is considerable evidence to support roles for Brm and Brg1 in the negative regulation of proliferation in cell culture in a manner that
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Figure 3. Multi-level regulation by pRB during cellular senescence.
(A) pRB inhibits cell cycle gene transcription by directly blocking transactivation by E2Fs. (B) pRB recruits co-repressor proteins like HDAC’s
that deacetylate histones at the promoter regions thereby further
repressing these genes. (C) pRB can also recruit chromatin regulating
proteins like Suv39h1, and HP1 that can propogate heterochromatin
and lead to large scale chromatin compaction resulting in permanent
silencing of proliferative genes.

pRB-dependent, as Rb1-/- mouse embryonic fibroblasts (MEFs)
show drastically decreased H3K9 methylation and HP1 protein
enrichment at the nucleosome positioned closest to the cyclin
E1 transcriptional start site. Thus, a pathway of deacetylation of
H3 preceding its methylation has emerged 21 (Fig. 3A and B).
Curiously, these early experiments did not offer insight into the
physiological need for this gene silencing pathway. Histone methylation is a stable repressive mark, whereas cyclin E1 expression
needs to be low through much of the G1 phase of the cell cycle
and high at the G1-S boundary, indicating a need for reversibility with each cell division cycle. This pathway will be discussed
again in a later section of this review on senescence, a permanent
form of cell cycle exit where histone methylation is prevalent.
In addition to regulating histone methylation at the transcriptional start site of cyclin E1, pRB could also play a role in propagating H3K9me3 to neighboring histone octamers. For example
methylation of histone H3 lysine 9 by Suv39h1 creates a binding
site for HP1. HP1 can, in turn, recruit more of these methylases to modify neighboring histones. This, in turn, would allow
new HP1 molecules to bind and for the process to be repeated.
Importantly, HDACs have also been shown to recruit HP1 proteins and Suv39h1 to promoters, suggesting that H3K9 could be
deacetylated to facilitate trimethylation and the spread of heterochromatin83 (Fig. 3C). Hence, pRB localization to a specific
gene locus, and recruitment of HDAC, HP1 and Suv39h1, can
potentially lead to spreading of this repressive histone mark. This
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is cooperative with pRB.19,74-76 Furthermore, ectopic proliferation
is detectable in adult Brm-/- mice,77 and cancer susceptibility of
Brg1+/- mice further suggests that they contribute to growth regulation in vivo.78 Brm and Brg1 were originally reported to interact
with pRB in an LXCXE dependent manner;19,20,74 however, this
is controversial, as more detailed analysis of this interaction fails
to confirm this conclusion.64 Detection of endogenous interactions between pRB and Brm or Brg1 is also limited to only a two
reports.19,20 Regardless of the precise mechanism of interaction
between pRB and Brm or Brg1, there is strong genetic interdependence in proliferative control that links them.
The mechanism of how these ATPases cooperate with pRB in
repressing E2F-dependent transcription also remains open ended.
Thus far, using transcriptional reporter assays, it has been determined that the ATPase activity of these proteins is required for
repression in cooperation with pRB, whereas the bromodomain
is dispensable.76 C33A cells that are resistant to the expression of a
constitutively active pRB mutant (PSM-RB) undergo arrest upon
ectopic co-expression of Brg1, suggesting chromatin remodeling
plays an important role in pRB-mediated arrest.75 Investigation
of chromatin structure at the cyclin A promoter (an E2F target)
demonstrates that it can’t be converted into a nuclease insensitive
state without Brm.79 In this way, silencing of this key cell cycle
target gene requires SWI/SNF to remodel chromatin and convert
it into a compacted, restriction endonuclease resistant form. How
this works is unclear, as it is unlikely to involve the recruitment
of another DNA binding transcriptional repressor, since negative
regulation of this promoter is largely E2F-dependent.80 One proposal is that SWI-SNF activity is necessary for loading a histone
deacetylase containing complex.81
Taken together, this example of cooperation between pRB and
Brm, or Brg1, further exemplifies how pRB recruits co-repressors
to E2F-responsive promoters. The consequence is again similar
to HDAC recruitment, in that the whole cyclin A promoter can
be silenced by chromatin structure changes that occur in a pRBdependent manner.
Histone methyl transferases. pRB has also been shown
to direct the addition of histone methylation marks to repress
transcription. In particular H3K9me3 and H4K20me3 can be
pRB-dependent modifications. In this section, we will focus on
H3K9me3 and the enzyme that adds it, because this modification is known to exist on pRB responsive gene promoters. The
data for H4K20me3 suggests a broader role in heterochromatin
organization beyond individual promoters and so it will be discussed later in this review.
In addition to regulating histone acetylation on E2Fresponsive promoters such as cyclin E1, pRB is also able to
recruit the histone methyl transferase Suv39h1 to trimethylate
H3K9.21,24 Methylation of this residue creates a binding site for
the chromo domain of the methyl lysine binding protein heterochromatin protein 1 (HP1).82 Importantly, endogenous pRB
co-immunoprecipitates with Suv39h1 and HP1 in an LXCXEdependent manner.21,24 In a striking parallel to HDAC function in repression of cyclin E1, H3K9me3 is found on the same
nucleosome at the transcriptional start site that is deacetylated
in an HDAC- and pRB-dependent manner. H3K9me3 is also

Everywhere: pRB Influences Chromatin Structure
of Large Heterochromatin Domains and Whole
Chromosomes
In addition to its regulation of transcription at specific loci, recent
studies suggest a role for pRB in influencing larger genomic
regions and even entire chromosomes. This function of pRB has
a direct effect on cell division and the maintenance of genome
stability. This section will highlight recent literature linking pRB
compaction of large-scale heterochromatin regions to their consequences on the genome.
pRB regulation of heterochromatin at repetitive sequences
throughout the genome. The RB protein and its family members have been implicated in the organization of repetitive elements at telomeres, long interspersed nuclear elements (LINE)
and pericentromeric heterochromatin.22,27,84 The consequences
of misregulation of these domains are lengthened telomere
repeats, deregulated expression of LINE transcripts and altered
centromere structure leading to mitotic abnormalities, respectively. Specifically, RB family-deficient mouse fibroblasts show
hypocondensed chromatin and display butterfly chromosomes,
whereby centromeres become joined, thus preventing separation in anaphase.22 A similar phenotype is also described in cells
that express a mutant form of pRB that is uniquely deficient for
LXCXE-type interactions called Rb1ΔL .25 This implies that pRB
is the pocket protein that is most responsible for organizing chromatin structure in this region.
Cells lacking all three RB-family proteins display decreased
levels of H4K20me3 in each of the three heterochromatin
domains described above.22,84 Perhaps not surprisingly, pRB
and its related family members can each physically interact with
Suv4–20h1/h2, the histone methyltransferases that trimethylate histone H4K20.22 Acute loss of pRB expression in fibroblasts
from Rb1lox/lox mice also results in a reduction in H4K20me3
at pericentric heterochromatin.26 Similarly, Rb1ΔL/ΔL cells have
reduced H4K20me3 at pericentromeric DNA.25 The exact role
of pRB in H4K20 histone methylation is not known. Despite
the reports of Suv4–20h1/h2 physically interacting with RB
family proteins, these enzymes are still targeted correctly to pericentric heterochromatin in their absence.22 Previous work studying H4K20 methylation suggests that H3K9me3 recruitment of
HP1 is essential for localization of Suv4–20h1/h2 and addition
of H4K20me3.85 This leaves in the question of how pRB facilitates H4K20me3. One potential clue comes from the analysis
of chromatin from Suv4–20h1/h2 double deficient mouse cells.
Cells devoid of these enzymes lack H4K20me3 at telomeres and
pericentromeric chromatin domains, and this leads to longer
telomeres but not the centromere fusions that best characterize Rb1 mutant cells.86 The differences in mitotic phenotypes
between Suv4–20h and Rb1 mutants suggest that diminished
H4K20me3 in Rb1 mutants could be a secondary consequence of

3194

altered chromatin structure, rather than a direct role for pRB in
the catalytic addition of this modification. For example, conditional deletion of Brg1 in mouse fibroblasts leads to dispersion of
H3K9me3 and disruption of H4K20me3 from pericentromeric
heterochromatin and lagging anaphase chromosomes.87 It is possible that pRB partially mediates Brg1 function in the assembly of pericentromeric heterochromatin, and in its absence, the
effects on histone tail modifications are a downstream effect.
Chromatin condensation mediated by pRB. In addition to
influencing H4K20me3 levels at centromeres, there are other
potential explanations for defective pericentromeric heterochromatin assembly. Recently, the fruit fly ortholog of pRB (Rbf)
has been shown to be able to regulate chromosome condensation through interactions with the Condensin II complex.30
Condensin complexes promote chromosome compaction during prophase.88,89 Rbf mutant chromosomes appear diffuse in
comparison with control chromosomes during prophase and
prometaphase in neuroblast chromosome spreads. Deficiency
for the Drosophila ortholog of Cap-D3, a condensin II subunit,
shows a similar phenotype in this and other assays of chromosome condensation. Longworth et al. also demonstrate that pRB
interacts specifically with condensin II, and that this interaction
is mediated through its LXCXE binding cleft.30 Furthermore,
Drosophila Cap-D3 requires Rbf for efficient localization to
chromatin.30 Mammalian cells expressing a pRB mutant defective in LXCXE interactions also display decreased loading of
condensin II on chromatin, whereas cohesin and condensin I
chromatin levels remain normal.31 Importantly, condensin II can
co-immunoprecipitate with pRB but not the Rb1ΔL mutant protein.31 Condensin II staining patterns reveal that it is most highly
concentrated at the centromere,90 a region that is abnormal in
Rb1ΔL/ΔL mouse chromosomes. Similar to the mitotic phenotypes
of Rb1ΔL/ΔL cells, diminished expression of condensin II components such as Cap-D3 results in delayed progression to metaphase
and lagging anaphase chromosomes.31,88,89
Taken together, pRB has a clear contribution to heterochromatin organization in relatively gene poor, repetitive regions of
the genome. Loss of chromatin structure in the pericentromeric
region is particularly noteworthy because of the mitotic defects
that it causes. Comparison of spontaneous tumors in Rb1ΔL/
ΔL
; Trp53-/- and Trp53-/- controls suggests that maintenance of
genome stability through chromosome segregation by pRB is
part of what makes it a tumor suppressor gene.31 This demonstrates that pRB makes critical contributions to chromatin organization both at large heterochromatin domains and individual
target genes. Cancer susceptibility studies cited above suggest
that pRB’s regulation of higher order chromatin structure may
be no less important in its role as a tumor suppressor than its
other functions that are more closely focused on transcriptional
control of individual genes.
All Three Levels of Control Rolled into One,
pRB Regulation of Cellular Senescence
Cellular senescence is a stable form of cell cycle arrest wherein cells
exit the cell cycle and can remain post-mitotic for an indefinite
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suggests that pRB may exert broader regulation of gene expression across promoters through histone methylation; however,
analysis of the size of H3K9me3 islands at these promoters has
yet to be reported.
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histone methyl transferase Suv39h1 by pRB to E2F regulated
promoters; however, differences in senescence between Rb1ΔL/
ΔL
and Suv39h1-/- mouse cells suggest that other methyltransferases, such as RIZ1, may also cooperate with pRB.94,104 Regardless
of the precise mechanism of H3K9me3 deposition, this further
illustrates how pRB-dependent chromatin regulation can exert
its influence on transcriptional repression across E2F-responsive
promoters (Fig. 3C).
Lastly, pRB plays a role in the formation of SAHFs themselves and thus also influences higher order chromatin structure
in senescence as well. Knock down of pRB results in decreased
formation of SAHFs.28,29 Since SAHFs represent the compaction of entire individual chromosomes,97,98 these structures represent considerable reorganization of higher order chromatin
structure that is pRB-dependent. The exact signals that trigger
this compaction and the mechanism of chromosome condensation that facilitates their formation is only beginning to be elucidated. Promyelocytic leukemia (PML) bodies appear to be one
component in the pathway to assembling SAHFs, and they have
recently been shown to co-localize to genes that are silenced in
a pRB-dependent manner.106 Furthermore, PML participates in
the incorporation of the repressive histone variant macroH2A1;
however, whether pRB is involved at this particular step or an
earlier one is unclear. Other broad changes to chromatin during
the formation of SAHFs are the ejection of histone H197 and the
incorporation of HMGA proteins.107 A logical expectation is that
these changes facilitate DNA bending during SAHF formation.
Again, it is unclear if pRB’s actual function in the induction of
chromosome condensation to form SAHFs mediates these events,
or if they are merely downstream of earlier pRB-dependent steps.
It is difficult to envision SAHF formation being driven purely
by pRB-dependent H3K9me3; however, as discussed above there
are many steps in SAHF formation and our knowledge of how
they take place remains limited.
In the context of pRB’s ability to regulate chromatin and
gene expression on many levels, it may not be surprising that the
multi-level regulation of gene expression and chromatin structure needed in senescence can be controlled by pRB. Senescence,
unlike other cell cycle exit paradigms, has distinguished itself as
having a bona fide tumor-suppressive role, and pRB may need
to use its complete arsenal of functions in order to maintain the
fidelity of this arrest. Since loss of pRB results in deregulated gene
expression, DNA synthesis and eventual escape from senescence,
it is imperative that we investigate further the steps in gene silencing and higher order chromatin assembly that are controlled by
pRB. In this way, we will come to a thorough understanding of
pRB function as a tumor suppressor protein.
Conclusions and Future Perspectives
Since being cloned in 1986, the retinoblastoma susceptibility
gene (Rb1) and its product, the retinoblastoma protein (pRB),
has been a subject of intense scientific research. Thanks to a considerable body of work that encompasses diverse model organisms, our understanding of pRB function has grown and evolved
during this time. A number of studies, both biochemical and
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period of time.91 Senescence can be triggered by telomere attrition, activated oncogenes, or other genotoxic stresses.91,92 It is now
believed that senescence acts as a barrier to cellular transformation by blocking proliferation of pre-cancerous cells before they
can evolve to acquire malignant traits.93,94
Phenotypically, senescent cells show a number of morphological changes as well as characteristic changes in gene expression
and chromatin structure.95 In general, they show downregulation
of proliferative genes,95 upregulation of anti proliferative genes29
and an increase in expression of inflammatory genes known as the
senescence associated secretory phenotype.96 At the chromatin
level, senescence is associated with global changes in heterochromatin organization. Senescent cells often display facultative heterochromatin structures in the nucleus that are called senescence
associated heterochromatic foci (SAHF).28 These structures are a
result of the compaction of individual chromosomes.97,98 SAHFs
are linked to transcriptional repression of proliferative genes as
they become enclosed in these foci leading to stable silencing.
A causal role for SAHFs during senescence has not been established, but it has been proposed that SAHFs contribute to the
long-term stability of senescent arrest by stably repressing the
expression of proliferative genes.99
Early experiments in cancer cells lacking pRB suggested a
critical role for it in senescence. Reintroduction of pRB into cancer cells can induce a senescent arrest.100 Conversely, acute loss
of pRB in senescent mouse embryonic fibroblasts (MEFs) results
in increased DNA synthesis, cell cycle re-entry and subsequent
reversal of cellular senescence.101 Rb1-/- MEF’s do arrest in culture
with features of senescence, but they escape from this arrest and
immortalize sooner than control cells expressing the wild type
protein.102,103 These studies suggested a key role for pRB in establishing the stability of senescent cell cycle arrest.
The retinoblastoma protein is capable of influencing senescence cell cycle arrest at various levels. First, pRB represses the
transcription of genes involved in DNA replication by directly
binding to and inhibiting E2F transcription factors and through
histone deacetylation of their respective promoters.28 The mechanism occurs essentially as described in earlier sections of this
review (see Fig. 3A and B). Indeed, pRB is found to be enriched
on E2F target gene promoters during senescence.28,29,104 Acute
knock down of pRB in primary human fibroblasts that are
induced to senesce with oncogenic ras (HrasV12) show deregulated DNA synthesis as reflected in continued incorporation of
BrdU and deregulated E2F transcription.29 Use of Rb1ΔL/ΔL fibroblasts in senescence induction demonstrates that early events in
proliferative arrest and downregulation of E2F transcriptional
targets take place.104 However, these mutant cells ultimately reenter the cell cycle and can resume proliferation, indicating that
later pRB-dependent steps in establishing a senescent arrest are
critical.
Second, pRB is required for the enrichment of repressive
histone methylation (H3K9me3) and the removal of activating
methylation (H3K4me3) on E2F target gene promoters during
senescence.28,104,105 Addition of H3K9me3 is defective in Rb1ΔL/ΔL
fibroblasts, implicating it in long-term stability of senescence.104
Presumably, histone methylation is through recruitment of the
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